Biohaven BHVN Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $103.83M-14.9% | $121.95M-13.6% | $141.17M-23.4% | $184.37M-1.7% | $187.58M+12.0% | ||
| $26.6M+28.0% | $20.79M-26.3% | $28.21M+3.2% | $27.33M-19.6% | $33.98M+51.3% | ||
| $130.43M-8.6% | $142.73M-15.7% | $169.38M-20.0% | $211.7M-4.5% | $221.56M+16.7% | ||
| -$130.43M+8.6% | -$142.73M+15.7% | -$169.38M+20.0% | -$211.7M+4.5% | -$221.56M-16.7% | ||
| $168K— | —— | -$3.84M-128% | $13.82M+2,702% | $493K-84.3% | ||
| -$130.26M+10.3% | -$145.2M+16.2% | -$173.22M+12.5% | -$197.89M+10.5% | -$221.07M-18.3% | ||
| $272K-22.5% | $351K+58.8% | $221K-15.3% | $261K-57.1% | $609K+1,169% | ||
| -$130.53M+10.3% | -$145.56M+16.1% | -$173.44M+12.5% | -$198.15M+10.6% | -$221.68M-18.6% | ||
| -$0.88+21.4% | -$1.12+31.7% | -$1.64+15.5% | -$1.94+10.6% | -$2.17-21.9% | ||
| -$128.06M+8.6% | -$140.16M+15.7% | -$166.26M+20.7% | -$209.72M+4.4% | -$219.32M-17.0% | ||
| -$130.43M+8.6% | -$142.73M+15.7% | -$169.38M+20.0% | -$211.7M+4.5% | -$221.56M-16.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Biohaven profitable?
- Biohaven is not currently profitable: it reported a net loss of $647.7M over the trailing twelve months.
- What is Biohaven's earnings per share?
- Biohaven's diluted EPS over the trailing twelve months is $-5.58.
- Where does Biohaven's income statement data come from?
- Every line is extracted from Biohaven's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.